Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
Open accessThe DOI matches its Crossref record; 48 of the 50 references it cites were found in a registry or an index.
Abstract
Bacteria can be genetically engineered to kill specific pathogens or inhibit their virulence. We previously developed a synthetic genetic system that allows a laboratory strain of Escherichia coli to sense and kill Pseudomonas aeruginosa in vitro . Here, we generate a modified version of the system, including a gene encoding an anti-biofilm enzyme, and use the probiotic strain Escherichia coli Nissle 1917 as host. The engineered probiotic shows in vivo prophylactic and therapeutic activity against P. aeruginosa during gut infection in two animal models ( Caenorhabditis elegans and mice). These findings support the further development of engineered microorganisms with potential prophylactic and therapeutic activities against gut infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“For example, Hwang et. al. demonstrated that the EcN-based gastrointestinal delivery of anti-biofilm enzyme, dispersin B (DspB), resulted in a reduction of pre-colonized P. aeruginosa abundance in both nematode and murine models29.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [29]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Regulating effector expression in response to bacterial quorum sensing molecules29, pH30, specific carbon sources31–33, temperature34, or combinations of these signals may allow for exquisitely tuned effector functions in various intestinal microenvironments7.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Interdependence of Cell Growth and Gene Expression: Origins and Consequences
Scott, M., Gunderson, C. W., Mateescu, E. M., Zhang, Z., & Hwa, T. (2010) · Science · doi:10.1126/science.1192588 · Cited by 1,470
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Tan, M.-W., Mahajan-Miklos, S., & Ausubel, F. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.715 · Cited by 1,002
Synchronized cycles of bacterial lysis for in vivo delivery
Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., et al. (2016) · Nature · doi:10.1038/nature18930 · Cited by 784
Refinement and standardization of synthetic biological parts and devices
Canton, B., Labno, A., & Endy, D. (2008) · Nature Biotechnology · doi:10.1038/nbt1413 · Cited by 753
The gastrointestinal tract. The “undrained abscess” of multiple organ failure
Marshall, J. C., Christou, N. V., & Meakins, J. L. (1993) · Annals of Surgery · doi:10.1097/00000658-199308000-00001 · Cited by 707
de Jonge, E., Schultz, M. J., Spanjaard, L., Bossuyt, P. M., Vroom, M. B., Dankert, J., & Kesecioglu, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14409-1 · Cited by 587
Bentley, W. E., Mirjalili, N., Andersen, D. C., Davis, R. H., & Kompala, D. S. (1990) · Biotechnology and Bioengineering · doi:10.1002/bit.260350704 · Cited by 536
Self-citationEngineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Lu, T. K., & Collins, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800442106 · Cited by 529
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001308 · Cited by 482
BglBrick vectors and datasheets: A synthetic biology platform for gene expression
Lee, T. S., Krupa, R. A., Zhang, F., Hajimorad, M., Holtz, W. J., Prasad, N., Lee, S. K., & Keasling, J. D. (2011) · Journal of Biological Engineering · doi:10.1186/1754-1611-5-12 · Cited by 476
Moskowitz, S. M., Foster, J. M., Emerson, J., & Burns, J. L. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.1915-1922.2004 · Cited by 397
Engineering microbes to sense and eradicate Pseudomonas aeruginosa , a human pathogen
Saeidi, N., Wong, C. K., Lo, T., Nguyen, H. X., Ling, H., Leong, S. S. J., Poh, C. L., & Chang, M. W. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.55 · Cited by 369
Self-citationItoh, Y., Wang, X., Hinnebusch, B. J., Preston, J. F., & Romeo, T. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.1.382-387.2005 · Cited by 322
Clinical use of E. coli Nissle 1917 in inflammatory bowel disease
Schultz, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20377 · Cited by 310
Enzymes in the D-alanine branch of bacterial cell wall peptidoglycan assembly
Walsh, C. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81624-1 · Cited by 287
Maltby, R., Leatham-Jensen, M. P., Gibson, T., Cohen, P. S., & Conway, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053957 · Cited by 285
Duan, F. F., Liu, J. H., & March, J. C. (2015) · Diabetes · doi:10.2337/db14-0635 · Cited by 263
Self-citationEngineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model
Duan, F., & March, J. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001294107 · Cited by 247
Self-citationRenwick, M. J., Brogan, D. M., & Mossialos, E. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2015.98 · Cited by 233
Leatham, M. P., Banerjee, S., Autieri, S. M., Mercado-Lubo, R., Conway, T., & Cohen, P. S. (2009) · Infection and Immunity · doi:10.1128/iai.00059-09 · Cited by 232
Alverdy, J., Holbrook, C., Rocha, F., Seiden, L., Licheng, R., Wu, Musch, M., Chang, E., Ohman, D., & Suh, S. (2000) · Annals of Surgery · doi:10.1097/00000658-200010000-00003 · Cited by 207
Watanabe, R., Matsumoto, T., Sano, G., Ishii, Y., Tateda, K., Sumiyama, Y., Uchiyama, J., Sakurai, S., Matsuzaki, S., Imai, S., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00635-06 · Cited by 206
Models of Caenorhabditis elegans Infection by Bacterial and Fungal Pathogens
Powell, J. R., & Ausubel, F. M. (2008) · Innate Immunity · doi:10.1007/978-1-59745-570-1_24 · Cited by 198
Necrotizing enterocolitis in the extremely low birth weight infant
Rowe, M. I., Reblock, K. K., Kurkchubasche, A. G., & Healey, P. J. (1994) · Journal of Pediatric Surgery · doi:10.1016/0022-3468(94)90264-x · Cited by 134
Genetically Programmable Pathogen Sense and Destroy
Gupta, S., Bram, E. E., & Weiss, R. (2013) · ACS Synthetic Biology · doi:10.1021/sb4000417 · Cited by 134
Hancock, V., Dahl, M., & Klemm, P. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.008672-0 · Cited by 130
Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer
Markou, P., & Apidianakis, Y. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00115 · Cited by 114
Optimal regulatory strategies for metabolic pathways in Escherichia coli depending on protein costs
Wessely, F., Bartl, M., Guthke, R., Li, P., Schuster, S., & Kaleta, C. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.46 · Cited by 108
Volzing, K., Borrero, J., Sadowsky, M. J., & Kaznessis, Y. N. (2013) · ACS Synthetic Biology · doi:10.1021/sb4000367 · Cited by 96
Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules
Westendorf, A. M., Gunzer, F., Deppenmeier, S., Tapadar, D., Hunger, J. K., Schmidt, M. A., Buer, J., & Bruder, D. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.10.023 · Cited by 94
Ling, H., Saeidi, N., Rasouliha, B. H., & Chang, M. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.021 · Cited by 92
Self-citationSt. Jean, A. T., Swofford, C. A., Panteli, J. T., Brentzel, Z. J., & Forbes, N. S. (2014) · Molecular Therapy · doi:10.1038/mt.2014.36 · Cited by 92
Wild, J., Hennig, J., Łobocka, M. B., Walczak, W., & Kłopotowski, T. (1985) · Molecular and General Genetics MGG · doi:10.1007/bf00383013 · Cited by 87
Shanghai fever: a distinct Pseudomonas aeruginosa enteric disease
Chuang, C.-H., Wang, Y.-H., Chang, H.-J., Chen, H.-L., Huang, Y.-C., Lin, T.-Y., Ozer, E. A., Allen, J. P., Hauser, A. R., & Chiu, C.-H. (2014) · Gut · doi:10.1136/gutjnl-2013-304786 · Cited by 84
Zaborina, O., Kohler, J. E., Wang, Y., Bethel, C., Shevchenko, O., Wu, L., Turner, J. R., & Alverdy, J. C. (2006) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-5-14 · Cited by 83
Okuda, J., Hayashi, N., Okamoto, M., Sawada, S., Minagawa, S., Yano, Y., & Gotoh, N. (2010) · Infection and Immunity · doi:10.1128/iai.00428-10 · Cited by 78
Koh, A. Y., Priebe, G. P., & Pier, G. B. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.2262-2272.2005 · Cited by 72
Pseudomonas aeruginosa Infection in Cancer Patients: Infectious complications of cancer
Rolston, K. V. I., & Bodey, G. P. (1992) · Cancer Investigation · doi:10.3109/07357909209032787 · Cited by 68
Novel bacteriocins with predicted tRNase and pore‐forming activities in Pseudomonas aeruginosa PAO1
Parret, A. H. A., & Mot, R. D. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01716.x · Cited by 35
Engineering commensal bacteria for prophylaxis against infection
Goh, Y.-L., He, H., & March, J. C. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.03.004 · Cited by 34
Self-citationNano-guided cell networks as conveyors of molecular communication
Terrell, J. L., Wu, H., Tsao, C., Barber, N. B., Servinsky, M. D., Payne, G. F., & Bentley, W. E. (2015) · Nature Communications · doi:10.1038/ncomms9500 · Cited by 34
Self-citationEnhanced Neutralization of HIV by Antibodies Displayed on the S-Layer of Caulobacter crescentus
Duval, M., Lewis, C. J., Nomellini, J. F., Horwitz, M. S., Smit, J., & Cavacini, L. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00509-11 · Cited by 16
Zuend, C. F., Nomellini, J. F., Ailon, E., Shanina, I., Sangsari, S., Cavacini, L. A., Smit, J., & Horwitz, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065965 · Cited by 15
Rasouliha, B. H., Ling, H., Ho, C. L., & Chang, M. W. (2013) · ChemBioChem · doi:10.1002/cbic.201300410 · Cited by 13
Self-citation
Cited by
Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance
Uruén, C., Chopo-Escuin, G., Tommassen, J., Mainar-Jaime, R. C., & Arenas, J. (2020) · Antibiotics · doi:10.3390/antibiotics10010003 · Cited by 769
“aeruginosa gut infection in animal models [321].”
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Gurbatri, C. R., Lia, I., Vincent, R., Coker, C., Castro, S., Treuting, P. M., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax0876 · Cited by 647
An ingestible bacterial-electronic system to monitor gastrointestinal health
Mimee, M., Nadeau, P., Hayward, A., Carim, S., Flanagan, S., Jerger, L., Collins, J., McDonnell, S., Swartwout, R., Citorik, R. J., et al. (2018) · Science · doi:10.1126/science.aas9315 · Cited by 606
Isabella, V. M., Ha, B. N., Castillo, M. J., Lubkowicz, D. J., Rowe, S. E., Millet, Y. A., Anderson, C. L., Li, N., Fisher, A. B., West, K. A., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4222 · Cited by 605
Synthetic Biology Tools to Engineer Microbial Communities for Biotechnology
McCarty, N. S., & Ledesma-Amaro, R. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.11.002 · Cited by 578
“While individual species have been engineered for therapeutic applications in vivo [86,87], it is only recently that synthetic microbial”
Background
Metadata
- Authors
- Hwang, I. Y., Koh, E., Wong, A., March, J. C., Bentley, W. E., Lee, Y. S., & Chang, M. W.
- Affiliations
- National University of Singapore (SG)
- Cornell University (US)
- University of Maryland, College Park (US)
- Corresponding author
- Chang, Matthew Wook
- ORCID
- Venue
- Nature Communications
- Published
- 2017-04-11
- Volume
- 8
- Issue
- 1
- Pages
- 15028-15028
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5394271
- OpenAlex
- W2605968366
- Cited by
- 472
- References
- 50
- Citations by year
- 2026: 44 · 2025: 53 · 2024: 51 · 2023: 55 · 2022: 68 · 2021: 44 · 2020: 54 · 2019: 53 · 2018: 41 · 2017: 9
- FWCI
- 31.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National University of Singapore (DPRT/943/09/14)
- National University Health System
- Defense Threat Reduction Agency (HDTRA1‐13‐0037, HDTRA1, DPRT/943/09/14)
- U.S. Air Force
- Medical Research Council
- National Medical Research Council (CBRG11nov109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- engineered probiotics, Escherichia coli, Pseudomonas aeruginosa, intestinal infection, Escherichia coli Nissle 1917, prophylaxis, therapeutic activities, Caenorhabditis elegans, mouse model
- MeSH terms
- Microorganisms, Genetically-Modified, Animals, Disease Models, Animal, Escherichia coli, Female, Gastroenteritis, Genetic Engineering, Mice, Inbred ICR, Pseudomonas aeruginosa, Pseudomonas Infections, Virulence, Caenorhabditis elegans, Probiotics, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.